Phylogica Limited
PYC Therapeutics Limited, a development-stage biotechnology company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and VP-002, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on … Read more
Market Cap & Net Worth: Phylogica Limited (PH7)
Phylogica Limited (MU:PH7) has a market capitalization of $2.01 Billion (€1.96 Billion) as of March 18, 2026. Listed on the MU stock exchange, this Germany-based company holds position #13001 globally and #1374 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Phylogica Limited's stock price €0.62 by its total outstanding shares 3180930048 (3.18 Billion).
Phylogica Limited Market Cap History: 2015 to 2025
Phylogica Limited's market capitalization history from 2015 to 2025. Data shows growth from $3.27 Million to $2.01 Billion (87.67% CAGR).
Phylogica Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Phylogica Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
19.99x
Phylogica Limited's market cap is 19.99 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $55.18 Million | $2.76 Million | -$1.95 Million | 19.99x | N/A |
Competitor Companies of PH7 by Market Capitalization
Companies near Phylogica Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Phylogica Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Phylogica Limited Historical Marketcap From 2015 to 2025
Between 2015 and today, Phylogica Limited's market cap moved from $3.27 Million to $ 2.01 Billion, with a yearly change of 87.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €2.01 Billion | 0.00% |
| 2024 | €2.01 Billion | +848.77% |
| 2023 | €212.23 Million | 0.00% |
| 2022 | €212.23 Million | 0.00% |
| 2021 | €212.23 Million | -25.29% |
| 2020 | €284.07 Million | +165.24% |
| 2019 | €107.10 Million | +315.19% |
| 2018 | €25.79 Million | -53.25% |
| 2017 | €55.18 Million | +1590.00% |
| 2016 | €3.27 Million | 0.00% |
| 2015 | €3.27 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Phylogica Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.01 Billion USD |
| MoneyControl | $2.01 Billion USD |
| MarketWatch | $2.01 Billion USD |
| marketcap.company | $2.01 Billion USD |
| Reuters | $2.01 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.